FKBP5 and cardiovascular disorder: Our overall objective in this study was to determine the association of chronic cortisol exposure, measured via percent methylation of FKBP5 at, specifically, intron 2, as was studied by Klengel, et al. [8], with markers of metabolic and cardiovascular disease in those with T2DM.